• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

心脏性猝死管理设备：成就、挑战与展望

Devices for management of sudden cardiac death: Successes, challenges and perspectives.

作者信息

Dagres Nikolaos, Hindricks Gerhard

机构信息

Department of Electrophysiology, University Leipzig - Heart Center, Leipzig, Germany.

Department of Electrophysiology, University Leipzig - Heart Center, Leipzig, Germany.

出版信息

Int J Cardiol. 2017 Jun 15;237:34-37. doi: 10.1016/j.ijcard.2017.03.053. Epub 2017 Mar 15.

DOI:10.1016/j.ijcard.2017.03.053
PMID:28385355
Abstract

Over the last decades, tremendous successes have been achieved in the management of sudden cardiac death in patients with heart failure by use of the implantable cardioverter-defibrillators. However, dramatic changes in the overall treatment of these patients have led to a significantly changed risk for sudden cardiac death. This renders a reevaluation of the role of devices for primary prevention of sudden cardiac death in patients receiving up-to-date optimal care imperative.

摘要

在过去几十年中，通过使用植入式心脏复律除颤器，心力衰竭患者心源性猝死的管理取得了巨大成功。然而，这些患者整体治疗的显著变化导致心源性猝死风险发生了显著改变。这使得重新评估设备在接受最新最佳治疗的患者心源性猝死一级预防中的作用变得势在必行。

相似文献

1
Devices for management of sudden cardiac death: Successes, challenges and perspectives.心脏性猝死管理设备：成就、挑战与展望
Int J Cardiol. 2017 Jun 15;237:34-37. doi: 10.1016/j.ijcard.2017.03.053. Epub 2017 Mar 15.
2
The subcutaneous implantable cardioverter-defibrillator: Current trends in clinical practice between guidelines and technology progress.皮下植入式心律转复除颤器：临床实践中指南与技术进步之间的当前趋势。
Eur J Intern Med. 2019 Jul;65:6-11. doi: 10.1016/j.ejim.2019.04.003. Epub 2019 Apr 17.
3
Development of the subcutaneous implantable cardioverter-defibrillator for reducing sudden cardiac death.用于降低心源性猝死的皮下植入式心律转复除颤器的研发。
Ann N Y Acad Sci. 2014 Nov;1329:1-17. doi: 10.1111/nyas.12550. Epub 2014 Oct 10.
4
The role of prophylactic implantable cardioverter defibrillators to prevent sudden cardiac death.
Can J Cardiol. 2000 Jun;16 Suppl C:26C-8C.
5
Sudden cardiac death: New approaches for implantable cardioverter-defibrillators (ICDs).心脏性猝死：植入式心脏复律除颤器（ICD）的新方法。
Int J Cardiol. 2017 Jun 15;237:38-41. doi: 10.1016/j.ijcard.2017.03.064. Epub 2017 Mar 18.
6
Implantable cardioverter-defibrillator: present and future indications.植入式心脏复律除颤器：当前及未来的适应症
Arch Mal Coeur Vaiss. 1996 Feb;89 Spec No 1:141-7.
7
Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator.心脏性猝死的预防：植入式心律转复除颤器的作用
Mt Sinai J Med. 2005 Jan;72(1):1-9.
8
Long-term outcome of implantable cardioverter-defibrillator implantation in secondary prevention of sudden cardiac death.植入式心脏复律除颤器植入用于心脏性猝死二级预防的长期预后
Arch Cardiovasc Dis. 2016 Oct;109(10):517-526. doi: 10.1016/j.acvd.2016.02.008. Epub 2016 Jun 21.
9
Can amiodarone prevent sudden cardiac death in patients with hemodynamically tolerated sustained ventricular tachycardia and coronary artery disease?
Cardiovasc Drugs Ther. 2005 May;19(3):219-26. doi: 10.1007/s10557-005-2502-8.
10
[The implantable cardioverter/defibrillator].[植入式心脏复律除颤器]
Herz. 1994 Oct;19(5):287-93.

引用本文的文献

1
Lack of Prognostic Value of T-Wave Alternans for Implantable Cardioverter-Defibrillator Benefit in Primary Prevention.T 波电交替对植入式心脏复律除颤器一级预防获益无预后价值。
J Am Heart Assoc. 2024 Jun 4;13(11):e032465. doi: 10.1161/JAHA.123.032465. Epub 2024 May 28.
2
Optimizing patient selection for primary prevention implantable cardioverter-defibrillator implantation: utilizing multimodal machine learning to assess risk of implantable cardioverter-defibrillator non-benefit.优化植入式心律转复除颤器一级预防的患者选择：利用多模态机器学习评估植入式心律转复除颤器无益风险。
Europace. 2023 Aug 2;25(9). doi: 10.1093/europace/euad271.
3
A long-term cost-effectiveness analysis of cardiac resynchronisation therapy with or without defibrillator based on health claims data.
基于健康声明数据的心脏再同步治疗（无论是否配备除颤器）的长期成本效益分析
Cost Eff Resour Alloc. 2022 Sep 2;20(1):48. doi: 10.1186/s12962-022-00384-x.
4
Survival of patients undergoing cardiac resynchronization therapy with or without defibrillator: the RESET-CRT project.接受心脏再同步治疗（有或无除颤器）患者的生存情况：RESET-CRT 项目。
Eur Heart J. 2022 Jul 14;43(27):2591-2599. doi: 10.1093/eurheartj/ehac053.
5
Q waves are the strongest electrocardiographic variable associated with primary prophylactic implantable cardioverter-defibrillator benefit: a prospective multicentre study.Q 波是与原发性预防植入式心脏除颤器获益最相关的最强心电图变量：一项前瞻性多中心研究。
Europace. 2022 May 3;24(5):774-783. doi: 10.1093/europace/euab260.
6
Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study.一级预防植入式心脏复律除颤器的临床疗效：欧盟CERT-ICD对照多中心队列研究结果
Eur Heart J. 2020 Sep 21;41(36):3437-3447. doi: 10.1093/eurheartj/ehaa226.
7
Rationale and design of the EU-CERT-ICD prospective study: comparative effectiveness of prophylactic ICD implantation.EU-CERT-ICD 前瞻性研究的原理和设计：预防性 ICD 植入的比较效果。
ESC Heart Fail. 2019 Feb;6(1):182-193. doi: 10.1002/ehf2.12367. Epub 2018 Oct 9.
8
Ventricular tachycardia-inducibility predicts arrhythmic events in post-myocardial infarction patients with low ejection fraction. A systematic review and meta-analysis.室性心动过速诱发性可预测低射血分数心肌梗死后患者的心律失常事件。一项系统评价和荟萃分析。
Int J Cardiol Heart Vasc. 2018 Jun 14;20:7-13. doi: 10.1016/j.ijcha.2018.06.002. eCollection 2018 Sep.
9
Short-term effects of ambient air pollutants and myocardial infarction in Changzhou, China.中国常州大气污染物与心肌梗死的短期影响。
Environ Sci Pollut Res Int. 2018 Aug;25(22):22285-22293. doi: 10.1007/s11356-018-2250-5. Epub 2018 May 28.